Literature DB >> 18190249

Epstein-Barr virus vaccine for the prevention of infectious mononucleosis--and what else?

Henry H Balfour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18190249     DOI： 10.1086/523815

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  gamma-Herpesvirus-induced protection against bacterial infection is transient.

Authors:  Eric J Yager; Frank M Szaba; Larry W Kummer; Kathleen G Lanzer; Claire E Burkum; Stephen T Smiley; Marcia A Blackman
Journal:  Viral Immunol       Date:  2009-02       Impact factor: 2.257

2.  Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load.

Authors:  Henry H Balfour; Priya Verghese
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

Review 3.  Progress, prospects, and problems in Epstein-Barr virus vaccine development.

Authors:  Henry H Balfour
Journal:  Curr Opin Virol       Date:  2014-03-15       Impact factor: 7.090

Review 4.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students.

Authors:  Henry H Balfour; Oludare A Odumade; David O Schmeling; Beth D Mullan; Julie A Ed; Jennifer A Knight; Heather E Vezina; William Thomas; Kristin A Hogquist
Journal:  J Infect Dis       Date:  2012-10-24       Impact factor: 5.226

Review 6.  Infectious mononucleosis.

Authors:  Henry H Balfour; Samantha K Dunmire; Kristin A Hogquist
Journal:  Clin Transl Immunology       Date:  2015-02-27

7.  Influence of Childhood Adversity and Infection on Timing of Menarche in a Multiethnic Sample of Women.

Authors:  Ayana K April-Sanders; Parisa Tehranifar; Erica Lee Argov; Shakira F Suglia; Carmen B Rodriguez; Jasmine A McDonald
Journal:  Int J Environ Res Public Health       Date:  2021-04-13       Impact factor: 4.614

8.  Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture.

Authors:  Jerome E Tanner; Jing Hu; Caroline Alfieri
Journal:  Cancers (Basel)       Date:  2018-04-09       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.